Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
Abstract Standard therapy of osteosarcoma (OS) and Ewing sarcoma (EW) rests on cytotoxic regimes, which are largely unsuccessful in advanced patients. Preclinical models are needed to break this impasse. A panel of patient-derived xenografts (PDX) was established by implantation of fresh, surgically...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/520fd06572ac4ed78a2083b0e3a1fa0d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|